4D Pharma PLC
LBPS
LBPS was delisted on the 24th of June, 2022.
4 hedge funds and large institutions have $2.38M invested in 4D Pharma PLC in 2021 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, reducing their positions, and 5 closing their positions.
11% less capital invested
Capital invested by funds: $2.67M → $2.38M (-$299K)
50% less funds holding
Funds holding: 8 → 4 (-4)
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RL
Ruffer LLP
London,
United Kingdom
|
+$2.27M |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
+$29.5K |
| 3 |
Morgan Stanley
New York
|
+$1.98K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UFM
Ursa Fund Management
Danville,
California
|
-$1.75M |
| 2 |
ACA
Apis Capital Advisors
New York
|
-$445K |
| 3 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$139K |
| 4 |
CCM
Context Capital Management
Lajolla,
California
|
-$57K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
RL
1
Ruffer LLP
London,
United Kingdom
| $2.09M | +$2.27M | +195,954 | New |
|
|
2
Morgan Stanley
New York
| $232K | +$1.98K | +171 | +0.8% |
|
|
3
Osaic Holdings
Scottsdale,
Arizona
| $44K | +$29.5K | +2,549 | +177% |
|
4
UBS Group
Zurich,
Switzerland
| $10K | – | – | – |
|
|
UFM
5
Ursa Fund Management
Danville,
California
| – | -$1.75M | -148,098 | Closed |
|
|
ACA
6
Apis Capital Advisors
New York
| – | -$445K | -37,657 | Closed |
|
|
AA
7
AQR Arbitrage
Greenwich,
Connecticut
| – | -$139K | -11,767 | Closed |
|
|
CCM
8
Context Capital Management
Lajolla,
California
| – | -$57K | -4,820 | Closed |
|
LBPS Hedge Fund Activity: Q2 2021 in Review
4 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in 4D Pharma PLC (LBPS) for Q2 2021, worth a combined $2.38M — down 11% from $2.67M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of LBPS and 1 opened new positions — a net loss of 4 holders — while 0 trimmed existing stakes and 2 added.
The largest buyer was Ruffer LLP, opening a new position worth an estimated $2.27M. The largest seller was Ursa Fund Management, exiting entirely with an estimated $1.75M sold.
- 4 institutional investors held 4D Pharma PLC (LBPS) as of Q2 2021, down from 8 in Q1 2021.
- Funds reported $2.38M of 4D Pharma PLC stock for Q2 2021, down 11% quarter-over-quarter.
- 1 fund opened new 4D Pharma PLC positions in Q2 2021 and 5 closed out, a net change of -4 holders.
- The largest 4D Pharma PLC buyer in Q2 2021 was Ruffer LLP, an estimated $2.27M added.
- The largest 4D Pharma PLC seller in Q2 2021 was Ursa Fund Management, an estimated $1.75M sold.
Based on aggregated 13F filings for Q2 2021.